Anthera Pharmaceuticals, Inc. (Nasdaq: ANTH) announced that the Data and Safety Monitoring Board (DSMB) completed its first pre-planned safety review ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE